Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Auton Neurosci ; 203: 17-24, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27887927

RESUMEN

It is described that fluoxetine treatment is able to induce ejaculatory disorders. However, the exact mechanism is still not fully understood. Therefore, this study was carried out to further evaluate the anti-ejaculatory effects of fluoxetine, using different approaches (in vitro or in vivo treatments), on the sympathetic neurotransmission of the rat vas deferens. Vas deferens from male Wistar rats were used to check the in vitro effects of fluoxetine 10-6M, 3.10-6M or 10-5M. Animals were also acutely (20mg/kg, i.p. 4h or 24h) or chronically (10mg/kg, i.p., 30days) treated with fluoxetine or drug-free vehicle. The vas deferens from non-treated and treated animals were isolated and mounted in an isolated organ bath for the study of the contractions induced by adrenergic agonists, tyramine, 5-HT, Ca2+ or electrical field stimulation. In vitro or acute treatment with fluoxetine decreased the contraction induced by agonists, Ca2+ or electrical field stimulation. The chronic treatment with fluoxetine decreased the contractions induced agonists, tyramine or Ca2+, but did not modify the contractions induced by electrical field stimulation. We have shown that in vitro or in vivo fluoxetine treatment is able to alter the sympathetic neurotransmission of the rat vas deferens which could be related to alterations in the calcium signalling.


Asunto(s)
Fluoxetina/administración & dosificación , Simpaticolíticos/administración & dosificación , Transmisión Sináptica/efectos de los fármacos , Conducto Deferente/efectos de los fármacos , Animales , Calcio/metabolismo , Evaluación Preclínica de Medicamentos , Eyaculación/efectos de los fármacos , Eyaculación/fisiología , Masculino , Ratas Wistar , Simpatomiméticos/farmacología , Transmisión Sináptica/fisiología , Factores de Tiempo , Técnicas de Cultivo de Tejidos , Conducto Deferente/fisiología
2.
Int J Food Sci Nutr ; 66(5): 579-86, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26088281

RESUMEN

It is known that red wine has cardioprotective properties. However, its influence is unknown about purinergic system. Therefore, we study the influence of the treatment with red wine or ethanol in purinergic neurotransmission. We used Wistar Kyoto rats (WKY), diabetic streptozotocin-induced WKY and spontaneously hypertensive rats (SHR), treated with red wine (12.5%) or ethanol (12.5%). The cardiovascular function stimulated with purinergic agonists and systolic blood pressure (SBP) was assessed. In atria of diabetics and SHRs, the P1 receptor response was decreased, unlike the P2 receptor response was increased. Likewise, in aorta the affinity to adenosine (ADO) was decreased from SHRs and diabetics. Furthermore, the P2X function was increased just SHRs. All these alterations were improved after treatment with red wine, resulting in reduction of SBP from diabetics and SHRs, but not when treated with ethanol. This study has important implications, because it is shown that consumption of red wine can improve cardiovascular system by purinergic neurotransmission.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Diabetes Mellitus Experimental/fisiopatología , Hipertensión/tratamiento farmacológico , Receptores Purinérgicos/metabolismo , Transmisión Sináptica/efectos de los fármacos , Vitis , Vino , Adenosina/metabolismo , Animales , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Etanol/farmacología , Hipertensión/etiología , Hipertensión/metabolismo , Masculino , Preparaciones de Plantas/farmacología , Preparaciones de Plantas/uso terapéutico , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Receptores Purinérgicos P1/metabolismo , Receptores Purinérgicos P2/metabolismo , Sistema Nervioso Simpático/efectos de los fármacos
3.
Eur J Pharmacol ; 599(1-3): 131-6, 2008 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-18840425

RESUMEN

Our aim was to check for calcium channel maturation and regulation on newborn rats during breastfeeding by mothers treated with the L-type calcium channel blocker nifedipine. Contractions by KCl and radioligand binding techniques were used to verify if Ca(2+) channels are modified in rat vas deferens of 40-day old litters that were breastfed by mothers injected daily with nifedipine during nursery. Injections were applied in the beginning (1st until 8th day), middle (9th until 16th day), or end (17th until 24th day) of nursery, to verify the period of highest susceptibility of newborn to nifedipine receptor regulation. Contractile responses revealed that only after the middle period of treatment of mothers the maximal effects (E(max)) induced in pups by KCl were increased by about 35%, without changes of apparent affinity (pD(2)). Additionally, binding studies with [(3)H] Isradipine in cell membrane preparations showed a greater density (B(max)) of Ca(2+) channels by about 55%, without changes of affinity (K(d)). Changes were not detected after treatment of mothers in the beginning or end of breastfeeding. In addition, in vas deferens of 60-day old litters, the E(max) returned to control values, showing that changes were not persistent. Moreover, body and vas deferens weights and blood testosterone of newborn were never changed. The histology of mammary gland was similar for treated and control mothers, suggesting a stable milk production. It is concluded that nifedipine treatment of mothers, if made during the 9th to 16th day of lactation, produced a short lasting reversible up-regulation of L-type Ca(2+) channels.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/efectos de los fármacos , Nifedipino/farmacología , Regulación hacia Arriba/efectos de los fármacos , Animales , Animales Recién Nacidos , Animales Lactantes , Bloqueadores de los Canales de Calcio/administración & dosificación , Canales de Calcio Tipo L/genética , Femenino , Lactancia/metabolismo , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/metabolismo , Nifedipino/administración & dosificación , Periodo Posparto , Cloruro de Potasio/farmacología , Unión Proteica , Ensayo de Unión Radioligante , Ratas , Ratas Wistar , Factores de Tiempo , Conducto Deferente/efectos de los fármacos , Conducto Deferente/metabolismo
4.
Eur J Pharmacol ; 470(1-2): 37-43, 2003 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-12787829

RESUMEN

The effect of nantenine, an aporphine alkaloid isolated from Ocotea macrophylla H.B.K., was studied on contractions and Ca(2+) translocation induced by noradrenaline, Ca(2+), or K(+) in the isolated rat vas deferens from reserpinized animals. Concentration-response curves of calcium chloride (CaCl(2)) were performed in the vas deferens, in a Ca(2+)-free nutrient solution, using potassium chloride (KCl, 80 mM) as a depolarizing agent. In these conditions, nantenine (2.35 x 10(-4) and 4.7 x 10(-4) M) significantly reduced the maximum contractions (E(max)) of Ca(2+) (IC(50)=2.6 x 10(-4) M) and noradrenaline (IC(50)=2.9 x 10(-4) M). The contractile responses were totally recovered after the withdrawal of nantenine. In addition, experiments performed to measure simultaneously the contraction and the increase of intracellular Ca(2+) induced by noradrenaline (10(-5) M) or KCl (80 mM) showed that nantenine (2.35 x 10(-4) and 4.7 x 10(-4) M) significantly decreased both effects. The results suggest that a reversible block of Ca(2+) entry could be involved on the non-competitive-like antagonism of nantenine in rat vas deferens.


Asunto(s)
Aporfinas/farmacología , Calcio/antagonistas & inhibidores , Contracción Muscular/efectos de los fármacos , Norepinefrina/farmacología , Cloruro de Potasio/farmacología , Animales , Calcio/fisiología , Cloruro de Calcio/farmacología , Relación Dosis-Respuesta a Droga , Masculino , Contracción Muscular/fisiología , Ocotea , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Ratas , Conducto Deferente/efectos de los fármacos , Conducto Deferente/fisiología
5.
Eur J Pharmacol ; 443(1-3): 13-8, 2002 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-12044786

RESUMEN

Radioligand binding and contraction techniques were used to verify if L-type Ca(2+) channels are modified in rat vas deferens after treatment with the blocker nifedipine (15 microg), injected at 7, 14, 21 and 28 days after birth. Vas deferens tissue was used 10, 30 and 90 days after the last injection, to verify if modifications are persistent. Binding studies with cell membranes, using [(3)H]isradipine, showed an increase of the density (B(max)) of Ca(2+) channels by more than 60%, after 10 and 30 days, without changes of affinity (K(d)). Maximal contractions (E(max)) of KCl, were increased by 106% and 37%, respectively, after 10 and 30 days, without changes of apparent affinity (pD(2)). After 90 days, the values of B(max), K(d), E(max) and pD(2) were not different from the controls. Differences were also not found for rats injected when adult. It is concluded that treatment of newborn, but not of adult, rats with nifedipine produced a long-lasting, though reversible, up-regulation of L-type Ca(2+) channels.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/metabolismo , Nifedipino/farmacología , Regulación hacia Arriba , Conducto Deferente/efectos de los fármacos , Animales , Animales Recién Nacidos , Bloqueadores de los Canales de Calcio/administración & dosificación , Canales de Calcio Tipo L/genética , Técnicas In Vitro , Masculino , Contracción Muscular , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Nifedipino/administración & dosificación , Cloruro de Potasio/farmacología , Unión Proteica , Ensayo de Unión Radioligante , Ratas , Ratas Wistar , Conducto Deferente/metabolismo , Conducto Deferente/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA